Effects of intravitreal corticosteroid in the treatment of Staphylococcus aureus-induced experimental endophthalmitis

Retina

Volumn 28, Issue 2, 2008, Pages 326-332

  De Kaspar, Herminia Miño ^a,b   Ta, Christopher N ^b   Engelbert, Michael ^a   Mette, Martina ^a   Thiel, Martin ^a   Kampik, Anselm ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Corticosteroid; Dexamethasone; Endophthalmitis; Intravitreal; Intravitreous; Steroid

Indexed keywords

AMIKACIN; DEXAMETHASONE; IMIPENEM; VANCOMYCIN; ANTIINFECTIVE AGENT; GLUCOCORTICOID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL EXAMINATION; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFECT; ELECTRORETINOGRAM; ENDOPHTHALMITIS; FEMALE; HISTOPATHOLOGY; MONOTHERAPY; NONHUMAN; RABBIT; STAPHYLOCOCCUS AUREUS; ANIMAL; BACTERIAL EYE INFECTION; DISEASE MODEL; DRUG COMBINATION; ELECTRORETINOGRAPHY; INJECTION; MICROBIOLOGY; PHYSIOLOGY; STAPHYLOCOCCUS INFECTION; VITREOUS BODY;

AMIKACIN; ANIMALS; ANTI-BACTERIAL AGENTS; DEXAMETHASONE; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; ELECTRORETINOGRAPHY; ENDOPHTHALMITIS; EYE INFECTIONS, BACTERIAL; FEMALE; GLUCOCORTICOIDS; IMIPENEM; INJECTIONS; RABBITS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VANCOMYCIN; VITREOUS BODY;

EID: 42449162428     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3181237cf8     Document Type: Article

References (25)

1. Group EVS. Results of the endophthalmitis vitrectomy study. A randomized trial of immediate vitrectomy and of intervenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol 1995;113:1479-1496.
2. Kattan HM, Flynn HW Jr, Pflugfelder SC, Robertson C, Forster RK. Nosocomial endophthalmitis survey. Current incidence of infection after intraocular surgery. Ophthalmology 1991;98:227-238.
3. Aaberg TM Jr, Flynn HW Jr, Schiffman J, et al. Nosocomial acute-onset postoperative endophthalmitis survey. A 10-year review of incidence and outcomes. Ophthalmology 1998;105:1004-1010.
4. Meredith T, Trabelsi A, Miller M, et al. Spontaneous sterilization in experimental Staphylococcus epidermidis endophthalmitis. Invest Ophthalmol Vis Sci 1990;31:181-186.
5. Beutler B, Krochin N, Milsark I, et al. Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science 1986;232:977-980.
6. Kern J, Lamb R, Reed J, et al. Dexamethasone inhibition of interleukin-1 beta production by human monocytes. J Clin Invest 1988;81:237-244.
7. Johnson MW, Doft BH, Kelsey SF, et al. The Endophthalmitis Vitrectomy Study. Relationship between clinical presentation and microbiologic spectrum. Ophthalmology 1997;104:261-272.
8. Han DP, Wisniewski SR, Wilson LA, et al. Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study [erratum appears in Am J Ophthalmol 1996;122:920]. Am J Ophthalmol 1996;122:1-17.
9. Microbiologic factors and visual outcome in the endophthalmitis vitrectomy study [see comments]. Am J Ophthalmol 1996;122:830-846.
10. O'Day DM, Jones DB, Patrinely J, et al. Staphylococcus epidermidis endophthalmitis. Visual outcome following noninvasive therapy. Ophthalmology 1982;89:354-360.
11. Mao LK, Flynn HW Jr, Miller D, et al. Endophthalmitis caused by Staphylococcus aureus. Am J Ophthalmol 1993;116:584-589.
12. Thompson WS, Rubsamen PE, Flynn HW Jr, et al. Endophthalmitis after penetrating trauma. Risk factors and visual acuity outcomes. Ophthalmology 1995;102:1696-1701.
13. Maxwell DJ, Brent B, Diamond JG, et al. Effect of intravitreal dexamethasone on ocular histopathology in a rabbit model of endophthalmitis. Ophthalmology 1991;98:1370-1375.
14. Meredith T, Aguilar H, Miller M, et al. Comparative treatment of experimental Staphylococcus epidermidis endophthalmitis. Arch Ophthalmol 1990;108:857-860.
15. Smith M, Sorenson J, D'Aversa G, et al. Treatment of experimental methicillin-resistant Staphylococcus epidermidis endophthalmitis with intravitreal vancomycin and intravitreal dexamethasone. The J Infect Dis 1997;175:462-466.
16. Yoshizumi M, Lee G, Equi R, et al. Timing of dexamethasone treatment in experimental Staphylococcus aureus endophthalmitis. Retina 1998;18:130-135.
17. Liu S, Way T, Rodrigues M, et al. Effects of intravitreal corticosteroids in the treatment of Bacillus cereus endophthalmitis. Arch Ophthalmol 2000;118:803-806.
18. Graham R, Peyman G. Intravitreal injection of dexamethasone. Arch Ophthalmol 1974;92:149-154.
19. Jett B, Jensen H, Atduri R, et al. Evaluation of therapeutic measures for treating endophthalmitis caused by isogenic toxin-producing and toxin-nonproducing Enterococcus faecalis strains. Invest Ophthalmol Vis Sci 1995;36:9-15.
20. Park S, Samiy N, Ruoff K, et al. Effect of intravitreal dexamethasone in treatment of pneumococcal endophthalmitis in rabbits. Arch Ophthalmol 1996;113:1324-1329.
21. Meredith TA, Aguilar HE, Drews C, et al. Intraocular dexamethasone produces a harmful effect on treatment of experimental Staphylococcus aureus endophthalmitis. Trans Am Ophthalmol Soc 1996;94:241-252.
22. Aguilar HE, Meredith TA, Drews C, et al. Comparative treatment of experimental Staphylococcus aureus endophthalmitis. Am J Ophthalmol 1996;121:310-317.
23. Park SS, Vallar RV, Hong CH, et al. Intravitreal dexamethasone effect on intravitreal vancomycin elimination in endophthalmitis. Arch Ophthalmol 1999;117:1058-1062.
24. Shah GK, Stein JD, Sharma S, et al. Visual outcomes following the use of intravitreal steroids in the treatment of postoperative endophthalmitis. Ophthalmology 2000;107:486-489.
25. Das T, Jalali S, Gothwal VK, et al. Intravitreal dexamethasone in exogenous bacterial endophthalmitis: results of a prospective randomised study. Br J Ophthalmol 1999;83:1050-1055.